|
|
"Hello! My name is Zoé Weydert. I’m working as an R&D Intern at InSphero and support the development of novel 3D microtissue models and liver toxicology studies. In September I will start my master in pharmaceutical biotechnology and I’m looking forward to doing my master thesis at InSphero."
|
InSphero featured in Tecan Journal
In the latest issue of the Tecan Journal InSphero‘s 3D microtissue technology is presented in combination with Tecan’s multimode reader Infinite 200 PRO, a system created for pharmaceutical and cosmetics companies to help reduce the costs and risks associated with drug development. View article. |
InSphero Success Story by Euresearch
Euresearch has written a success story on InSphero and its collaborative research project “The Body-on-a-Chip” funded by the European Union. The project for next-generation drug screening device is coordinated by InSphero and developed together with leading academic and industrial partners. Read more. |
|
3D Microtissues for advanced cardiotoxicity testing
InSphero is developing a 3D microtissue in vitro model for cardiotoxicity testing in collaboration with Christian Zuppinger from the University of Bern showing long term viability and contractile function for up to 3 weeks. Find out more and download poster. |
InSphero secures CHF 2 Million Financing
To expand its rapidly growing business in the US and East Asia and to meet the increasing customer demand for its 3D microtissues InSphero successfully closed a financing round of CHF 2 million last month. Read more in media release. |
3D cell culture literature picks – June 2013
Our applications team has reviewed a small selection of current 3D-cell-culture journal papers to keep you updated about recent developments in 3D.
|
|
|
|
|
